Oxgene introduces tessa technology for robust and reproducible aav manufacture at scale

Oxgene™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-
ABEO Ratings Summary
ABEO Quant Ranking